Pediatric Clinic and Rare Disease Department, Antonio Cao Pediatric Hospital, Cagliari, Italy.
Pediatric Department, San Paolo Hospital, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy.
Metab Brain Dis. 2019 Oct;34(5):1515-1518. doi: 10.1007/s11011-019-00453-w. Epub 2019 Jul 2.
Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare autosomal recessive disorder of γ-aminobutyric acid (GABA) catabolism caused by mutations in the gene coding for succinic semialdehyde dehydrogenase (ALDH5A1). The abnormal levels of GHB detected in the brain and in all physiological fluids of SSADHD patients represent a diagnostic biochemical hallmark of the disease. Here we report on the clinical and molecular characterization of two unrelated Italian patients and the identification of two novel mutations: a 22 bp DNA duplication in exon 1, c.114_135dup, p.(C46AfsX97), and a non-sense mutation in exon 10, c.1429C > T, p.(Q477X). The two patients showed very different clinical phenotypes, coherent with their age. These findings enrich the characterization of SSADHD families and contribute to the knowledge on the progression of the disease.
琥珀酸半醛脱氢酶缺乏症 (SSADHD) 是一种罕见的γ-氨基丁酸 (GABA) 分解代谢的常染色体隐性遗传病,由编码琥珀酸半醛脱氢酶 (ALDH5A1) 的基因突变引起。在 SSADHD 患者的大脑和所有生理液中检测到的异常水平的 GHB 代表该疾病的诊断生化标志。在这里,我们报告了两位无关的意大利患者的临床和分子特征,并鉴定了两种新的突变:外显子 1 中的 22 bp DNA 重复,c.114_135dup,p.(C46AfsX97),以及外显子 10 中的无义突变,c.1429C>T,p.(Q477X)。这两位患者表现出非常不同的临床表型,与他们的年龄一致。这些发现丰富了 SSADHD 家族的特征,并有助于了解疾病的进展。